Medtronic plc recently announced new clinical data for the Harmony Transcatheter Pulmonary Valve (TPV) from its early feasibility study, showing improved hemodynamics from baseline and consistent valve performance at one year. Presented at the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, the positive new data from the first-of-its-kind early feasibility study led the U.S. Food and Drug Administration (FDA) to also recently approve the initiation of a Pivotal Investigational Device Exemption (IDE) study to evaluate the valve’s safety and effectiveness.

St. Jude Medical Inc. announced this week the U.S. Food and Drug Administration (FDA) approval and launch of the Amplatzer PFO Occluder to help reduce the risk of recurrent ischemic strokes in patients diagnosed with a patent foramen ovale (PFO). With the approval, patients in the United States with a PFO (a small opening between the upper chambers of the heart) who have suffered an ischemic stroke — a stroke resulting from blockages in the blood supply to the brain — will now have access to a closure device proven to reduce their risk of recurrent stroke, rather than relying on medical management alone.

Researchers at Stanford University have demonstrated for the first time the use of a dual optical and positron emission tomography (PET)/computed tomography (CT) activity-based probe to detect atherosclerotic plaques. The study is published in the October issue of The Journal of Nuclear Medicine.

November 1, 2016 — Medtronic plc unveiled the first clinical outcomes of its novel Drug-Filled Stent (DFS) from the RevElution Trial at the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, held Oct. 29-Nov. 3 in Washington, D.C.

Edwards Lifesciences Corp. announced new five-year hemodynamic data from the PARTNER Trial demonstrating excellent durability of the first-generation Edwards Sapien transcatheter heart valve (THV). This evaluation of 2,404 patients, encompassing 10,560 echoes and 6,493 patient years of follow-up, is the largest core lab based study of transcatheter heart valves to date.

Medtronic plc presented new positive data from two large registries aimed at evaluating 30-day clinical performance outcomes for the self-expanding, recapturable and repositionable CoreValve Evolut R System in “real-world” severe aortic stenosis patient populations at the Transcatheter Cardiovascular Therapeutics (TCT) Annual Meeting.

In an effort to improve patient care, Children's Hospital of Philadelphia's (CHOP) Information Services team is using data and advanced analytics to screen patients for venous thromboembolism (VTE). This innovative technology is being honored by Drexel University and CIO.com in their inaugural Analytics 50 award ceremony, which will be held on Nov. 9, 2016 at Drexel University's LeBow College of Business.

SecurityScorecard, a security rating and continuous risk monitoring platform, released its 2016 Healthcare Industry Cybersecurity Report in October. The report is a comprehensive analysis exposing alarming cybersecurity vulnerabilities across 700 healthcare organizations including medical treatment facilities, health insurance agencies and healthcare manufacturing companies. Security breaches in this industry pose devastating consequences, according to the company, because they can render an entire system or network inoperable, creating a life or death situation that needs immediate attention.

At the 2016 annual meeting of the Radiological Society of North America (RSNA 2016), GE Healthcare will introduce the Revolution CT (computed tomography) scanner with Whisper Drive technology, designed to take high-speed scans that allow full imaging of the heart in just one heartbeat.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now